Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Free Cash Flow (2018 - 2025)

Historic Free Cash Flow for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$7.0 million.

  • Dna X's Free Cash Flow fell 116967.51% to -$7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.0 million, marking a year-over-year decrease of 47278.93%. This contributed to the annual value of -$8.7 million for FY2024, which is 11281.8% down from last year.
  • As of Q3 2025, Dna X's Free Cash Flow stood at -$7.0 million, which was down 116967.51% from -$4.9 million recorded in Q2 2025.
  • In the past 5 years, Dna X's Free Cash Flow ranged from a high of $820000.0 in Q2 2023 and a low of -$17.6 million during Q4 2021
  • In the last 5 years, Dna X's Free Cash Flow had a median value of -$4.2 million in 2023 and averaged -$4.5 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first soared by 11085.93% in 2022, then plummeted by 475151.52% in 2025.
  • Quarter analysis of 5 years shows Dna X's Free Cash Flow stood at -$17.6 million in 2021, then surged by 87.35% to -$2.2 million in 2022, then surged by 83.69% to -$363000.0 in 2023, then tumbled by 1144.35% to -$4.5 million in 2024, then crashed by 55.72% to -$7.0 million in 2025.
  • Its Free Cash Flow stands at -$7.0 million for Q3 2025, versus -$4.9 million for Q2 2025 and -$9.6 million for Q1 2025.